| Line Item | 2025-09-30 | Y/Y |
|---|---|---|
| Revenue | $2.67B | -16.0% |
| Cost of Revenue | $1.77B | -16.6% |
| Gross Profit | $900.8M | -14.7% |
| R&D Expense | $34.1M | -7.1% |
| Interest Expense | $94.5M | -22.2% |
| Pre-tax Income | -$2.4M | +98.3% |
| Income Tax | -$54.5M | -184.1% |
| Net Income | $43.1M | +120.4% |
| EPS (Basic) | $0.61 | +120.3% |
| EPS (Diluted) | $0.61 | +120.3% |
| Line Item | 2025-09-30 | Y/Y |
|---|---|---|
| Cash & Equivalents | $164.8M | -17.3% |
| Inventory | $344.0M | -34.5% |
| Current Assets | $1.24B | -17.8% |
| Total Assets | $4.47B | -14.7% |
| Current Liabilities | $1.02B | -14.2% |
| Long-term Debt | $1.52B | -19.5% |
| Total Liabilities | $3.04B | -19.5% |
| Line Item | 2025-09-30 | Y/Y |
|---|---|---|
| Financing Cash Flow | -$279.4M | -23.0% |
| Stockholders' Equity |
| $1.39B |
| -2.6% |